- TRELEGY Ellipta Summary of Product Characteristics, 2017.
- Lipson DA et al. Am J Respir Crit Care Med. 2017; 196(4): 438-446.
- van der Palen J et al. NPJ Prim Care Respir Med 2016; 26: 16079
- Riley JH et al. Int J Chron Obstruct Pulmon Dis 2016; 11: 1873-80.
- Svedsater H et al. BMC Pulm Med 2013; 13: 72.
TRELEGY Ellipta was developed in collaboration with INNOVIVA Inc.
© 2017 GlaxoSmithKline Group of Companies. TRELEGY and Ellipta are trademarks of the GSK group of companies.
Materials supplied by the above-country business unit to LOCs, for localisation must be subject to local Medical and/or Regulatory review and approval prior to external distribution